Rutter, H. (Harry)
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
4 results
Search Results
Now showing 1 - 4 of 4
- The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality(Elsevier BV, 2022) Yki-Järvinen, H. (Hannele); Christos, L. (Lionis); Verkade, H.J. (Henkjan J.); Karlsen, T.H. (Tom H.); Pryke, R. (Rachel); Flisiak, R. (Robert); Kelly, D. (Deirdre); Simonova, M. (Marieta); Serra-Burriel, M. (Miquel); Ginès, P. (Pere); Lerouge, A. (Alienor); Hutchinson, S.J. (Sharon J.); Barrett, D. (Damon); Manns, M.P. (Michael P.); Burra, P. (Patrizia); Mendive, J.M. (Juan M.); Ma, A.T. (Ann T.); Devaux, M. (Marion); Cecchini, M. (Michele); Belloni, A. (Annalisa); Sheena, B. (Brittney); Sangro, B. (Bruno); Marchesini, G. (Giulio); Ashworth-Dirac, M. (Mae); Reic, T. (Tatjana); Cortez-Pinto, H. (Helena); Zelber-Sagi, S. (Shira); Treloar, C. (Carla); Targher, G. (Giovanni); Cucchetti, A. (Alessandro); Carrieri, P. (Patrizia); Petersen, C. (Claus); Scott, N. (Nick); Byrne, C.D. (Chris D.); Buti, M. (Maria); Fabrellas, N. (Nuria); Rutter, H. (Harry); Hellard, M. (Margaret); Bugianesi, E. (Elisabetta); Schramm, C. (Christoph); Martin, N.K. (Natasha K.); Taylor, A. (Alison); Parés, A. (Albert); Lazarus, J.V. (Jeffrey V.); Sturm, E. (Ekkehard); Ponsioen, C.Y. (Cyriel Y.); Tur-Sinai, A. (Aviad); Pose, E. (Elisa); Johnson, P.J. (Philip J.); Burton, R. (Robyn); Mazzaferro, V. (Vicenzo); Newsome, P. (Philip N.); Ninburg, M. (Michael); Rhodes, T. (Tim); Sheron, N. (Nick); Dusheiko, G. (Geoffrey); Graupera, I. (Isabel)Liver diseases have become a major health threat across Europe, and the face of European hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral hepatitis B, the increasingly widespread unhealthy use of alcohol, the epidemic of obesity, and undiagnosed or untreated liver disease in migrant populations. Consequently, Europe is facing a looming syndemic, in which socioeconomic and health inequities combine to adversely affect liver disease prevalence, outcomes, and opportunities to receive care. In addition, the COVID-19 pandemic has magnified pre-existing challenges to uniform implementation of policies and equity of access to care in Europe, arising from national borders and the cultural and historical heterogeneity of European societies. In following up on work from the Lancet Commission on liver disease in the UK and epidemiological studies led by the European Association for the Study of the Liver (EASL), our multidisciplinary Commission, comprising a wide range of public health, medical, and nursing specialty groups, along with patient representatives, set out to provide a snapshot of the European landscape on liver diseases and to propose a framework for the principal actions required to improve liver health in Europe. We believe that a joint European process of thinking, and construction of uniform policies and action, implementation, and evaluation can serve as a powerful mechanism to improve liver care in Europe and set the way for similar changes globally. On the basis of these data, we present ten actionable recommendations, half of which are oriented towards health-care providers and half of which focus primarily on health policy. A fundamental shift must occur, in which health promotion, prevention, proactive casefinding, early identification of progressive liver fibrosis, and early treatment of liver diseases replace the current emphasis on the management of end-stage liver disease complications. A considerable focus should be put on underserved and marginalised communities, including early diagnosis and management in children, and we provide proposals on how to better target disadvantaged communities through health promotion, prevention, and care using multilevel interventions acting on current barriers. Underlying this transformative shift is the need to enhance awareness of the preventable and treatable nature of many liver diseases. Therapeutic nihilism, which is prevalent in current clinical practice across a range of medical specialities as well as in many patients themselves, has to end. We wish to challenge medical specialty protectionism and invite a broad range of stakeholders, including primary care physicians, nurses, patients, peers, and members of relevant communities, along with medical specialists trained in obesity, diabetes, liver disease, oncology, cardiovascular disease, public health, addictions, infectious diseases, and more, to engage in integrated person-centred liver patient care across classical medical specialty boundaries. This shift includes a revision in how we converse about liver disease and speak with our patients, and a reappraisal of disease-related medical nomenclature conducted to increase awareness and reduce the social stigmatisation associated with liver disease. Reimbursement mechanisms and insurance systems must be harmonised to account for patient-centric, multimorbidity models of care across a range of medical specialties, and the World Health Assembly resolution to improve the transparency and fairness of market prices for medicines throughout Europe should be reinforced. Finally, we outline how Europe can move forward with implementation of effective policy action on taxation, food reformulation, and product labelling, advertising, and availability, similar to that implemented for tobacco, to reduce consumption of alcohol, ultraprocessed foods, and foods with added sugar, especially among young people. We should utilise the window of opportunity created by the COVID-19 pandemic to overcome fragmentation and the variability of health prevention policies and research across Europe. We argue that the liver is a window to the 21st-century health of the European population. Through our proposed syndemic approach to liver disease and social and health inequities in Europe, the liver will serve as a sentinel for improving the overall health of European populations.
- Clustering of Multiple Energy Balance-Related Behaviors in School Children and Its Association with Overweight and Obesity—WHO European Childhood Obesity Surveillance Initiative (COSI 2015–2017)(MDPI AG, 2019) Abdrakhmanova, S. (Shynar); Rito, A.I. (Ana Isabel); Hyska, J. (Jolanda); Pérez-Farinós, N. (Napoleón); Sant’Angelo, V.F. (Victoria Farrugia); Hejgaard, T. (Tatjana); Ovezmyradova, G. (Guljemal); Shengelia, L. (Lela); Braunerová, R.T. (Radka Taxová); Rutter, H. (Harry); Milanovic, S.M. (Sanja Music); Murrin, C.M. (Celine M.); Kelleher, C.C. (Cecily C.); Kujundzic, E. (Enisa); Breda, J. (João); Bel-Serrat, S. (Silvia); Petrauskiene, A. (Ausra); Buoncristiano, M. (Marta); Ojeda-Rodríguez, A. (Ana); Fijalkowska, A. (Anna); Huidumac, C. (Constanta); Duleva, V. (Vesselka); Heinen, M.M. (Mirjam M.)It is unclear how dietary, physical activity and sedentary behaviors co-occur in school-aged children. We investigated the clustering of energy balance-related behaviors and whether the identified clusters were associated with weight status. Participants were 6- to 9-year-old children (n = 63,215, 49.9% girls) from 19 countries participating in the fourth round (2015/2017) of the World Health Organization (WHO) European Childhood Obesity Surveillance Initiative. Energy balance-related behaviors were parentally reported. Weight and height were objectively measured. We performed cluster analysis separately per group of countries (North Europe, East Europe, South Europe/Mediterranean countries and West-Central Asia). Seven clusters were identified in each group. Healthier clusters were common across groups. The pattern of distribution of healthy and unhealthy behaviors within each cluster was group specific. Associations between the clustering of energy balance-related behaviors and weight status varied per group. In South Europe/Mediterranean countries and East Europe, all or most of the cluster solutions were associated with higher risk of overweight/obesity when compared with the cluster 'Physically active and healthy diet'. Few or no associations were observed in North Europe and West-Central Asia, respectively. These findings support the hypothesis that unfavorable weight status is associated with a particular combination of energy balance-related behavior patterns, but only in some groups of countries.
- Balancing upstream and downstream measures to tackle the obesity epidemic: a position statement from the European Association for the Study of Obesity(Karger, 2017) Henauw, S. (Stefaan) de; Lahti-Koski, M. (Marjaana); Bes-Rastrollo, M. (Maira); Rasmussen, F. (Finn); Mullerova, D. (Dana); Rutter, H. (Harry); Rissanen, A. (Aila); Lehtinene-Jacks, S. (Susanna); Visscher, T.L.S. (Tommy L. S.)
- European association for the study of obesity position statement on the global COVID-19 pandemic(Karger, 2020) Farpour-Lambert, N. (Nathalie); Busetto, L. (Luca); Ramos-Salas, X. (Ximena); Woodward, E. (Euan); Holm, J.C. (Jens-Christian); Lehtinen-Jacks, S. (Susanna); Mullerova, D. (Dana); Frühbeck, G. (Gema); Yumuk, V. (Volkan); Halford, J.C.G. (Jason C. G.); O’Malley, G. (Grace); Handjieva-Darlenska, T. (Teodora); Rutter, H. (Harry); Sagen, J.V. (Jorn V.); Dicker, D. (Dror); Hassapidou, M. (Maria); Lyn-Baker, J. (Jennifer); Goossens, G.H. (Gijs H.)COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, was declared a pandemic by the World Health Organization on March 12, 2020. The European Association for the Study of Obesity (EASO), as a scientific and medical society dedicated to the promotion of health and well-being, is greatly concerned about this global health challenge and its significant impacts on individuals, families, communities, health systems, nations, and wider society.